Success Stories: EB-1A Approved for Postdoctoral Researcher in Pennsylvania in the Field of Radiology
Client’s Testimonial:
You guys were exceptional and everything was prompt within the specified time. I have already recommended lot of my friends to go with you guys. Thank you Chen Team.
Position at the Time of Case Filing: Postdoctoral Researcher
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Pennsylvania
Approval Notice Date: August 26, 2014
Processing Time: 1 month, 15 days (13 days after Premium Processing Requested)
In this case, the client that we had the opportunity to work with was a Postdoctoral Researcher from India in the field of Radiology. He had conducted his research in the highly specialized areas of spectroscopy, the study of amyloid proteins, and the innovation of new types of imaging. His work had resulted in 22 peer-reviewed scientific articles and 40 presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 610 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 6 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] conducted a series of studies which solved the structures of rat and human IAPP and illustrated their differences. This knowledge helps in our study of diabetes and the creation of new drug pathways for the disease. As nearly 26 million people struggle with type II diabetes in the United States of America alone, where the disease has reached epidemic proportions, this is a most valuable area of research.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Radiology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 1 month and 15 days.